Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations-Reference-Cited by-同舟云学术

Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations

Published:2021-07 Issue: Volume:106 Page:106432
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Mittendorf Kathleen F.,Kauffman Tia L.,Amendola Laura M.,Anderson Katherine P.,Biesecker Barbara B.,Dorschner Michael O.,Duenas Devan M.,Eubanks Donna J.,Feigelson Heather Spencer,Gilmore Marian J.,Hunter Jessica Ezzell,Joseph Galen,Kraft Stephanie A.,Lee Sandra Soo Jin,Leo Michael C.,Liles Elizabeth G.,Lindberg Nangel M.,Muessig Kristin R.,Okuyama Sonia,Porter Kathryn M.,Riddle Leslie S.,Rolf Bradley A.,Rope Alan F.,Zepp Jamilyn M.,Jarvik Gail P.,Wilfond Benjamin S.,Goddard Katrina A.B.

Funder

National Human Genome Research Institute

National Cancer Institute

National Institute on Minority Health and Health Disparities

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference81 articles.

1. Hereditary cancer predisposition syndromes;Garber;J. Clin. Oncol.,2005

2. Highly penetrant hereditary cancer syndromes;Nagy;Oncogene,2004

3. BRCA1 and BRCA2 hereditary breast and ovarian cancer;Petrucelli,1993